PWMG
EBS icon

Prestige Wealth Management Group’s Emergent Biosolutions EBS Stock Holding History

Prestige Wealth Management Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-86
Closed -$1.02K – 1089
2022
Q4 		$1.02K Buy
+86
New +$1.33K ﹤0.01% 971
2022
Q2 		– Sell
-8
Closed – – 992
2022
Q1 		$0 Buy
+8
New +$353 ﹤0.01% 993

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prestige Wealth Management Group's EBS Position: Q1 2023 in Review

Prestige Wealth Management Group sold out of Emergent Biosolutions (EBS) in Q1 2023, closing a stake of 86 shares — an estimated $1.02K sold.

Prestige Wealth Management Group first reported a position in EBS in Q1 2022 and held it in 2 quarters. The position peaked at $1.02K in Q4 2022. 191 funds tracked by Wall St. Rank hold EBS as of Q1 2023.

  • Prestige Wealth Management Group reported no remaining Emergent Biosolutions position as of Q1 2023 after selling out during the quarter.
  • Prestige Wealth Management Group sold 86 Emergent Biosolutions shares in Q1 2023, an estimated $1.02K.
  • Prestige Wealth Management Group first reported a position in Emergent Biosolutions in Q1 2022 and held it in 2 quarters.
  • Prestige Wealth Management Group's Emergent Biosolutions position peaked at $1.02K in Q4 2022.
  • 191 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2023.

Based on Prestige Wealth Management Group's 13F filing for Q1 2023, filed 16 May 2023.